BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19395246)

  • 41. Resveratrol protects against vinorelbine-induced vascular endothelial cell injury.
    Zhang J; Tong N; Chen Y; Li P; Yang S; Zhao X
    Toxicol Mech Methods; 2013 Nov; 23(9):665-71. PubMed ID: 23977833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles.
    Khan MI; Mohammad A; Patil G; Naqvi SA; Chauhan LK; Ahmad I
    Biomaterials; 2012 Feb; 33(5):1477-88. PubMed ID: 22098780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resveratrol protects primary rat hepatocytes against necrosis induced by reactive oxygen species.
    Rubiolo JA; Vega FV
    Biomed Pharmacother; 2008 Nov; 62(9):606-12. PubMed ID: 18674878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
    Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential internalization of amphotericin B--conjugated nanoparticles in human cells and the expression of heat shock protein 70.
    Paulo CS; Lino MM; Matos AA; Ferreira LS
    Biomaterials; 2013 Jul; 34(21):5281-93. PubMed ID: 23578560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancing delivery and cytotoxicity of resveratrol through a dual nanoencapsulation approach.
    Soo E; Thakur S; Qu Z; Jambhrunkar S; Parekh HS; Popat A
    J Colloid Interface Sci; 2016 Jan; 462():368-74. PubMed ID: 26479200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resveratrol induces apoptotic cell death in rat H4IIE hepatoma cells but necrosis in C6 glioma cells.
    Michels G; Wätjen W; Weber N; Niering P; Chovolou Y; Kampkötter A; Proksch P; Kahl R
    Toxicology; 2006 Aug; 225(2-3):173-82. PubMed ID: 16843582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition.
    Lamprecht A; Benoit JP
    J Control Release; 2006 May; 112(2):208-13. PubMed ID: 16574265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Flavin Oxidase-Induced ROS Generation Modulates PKC Biphasic Effect of Resveratrol on Endothelial Cell Survival.
    Posadino AM; Giordo R; Cossu A; Nasrallah GK; Shaito A; Abou-Saleh H; Eid AH; Pintus G
    Biomolecules; 2019 May; 9(6):. PubMed ID: 31151226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
    Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
    J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dosage effects of resveratrol on ethanol-induced cell death in the human K562 cell line.
    Chan WH; Chang YJ
    Toxicol Lett; 2006 Feb; 161(1):1-9. PubMed ID: 16125344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cellular uptake and reactive oxygen species modulation of cerium oxide nanoparticles in human monocyte cell line U937.
    Lord MS; Jung M; Teoh WY; Gunawan C; Vassie JA; Amal R; Whitelock JM
    Biomaterials; 2012 Nov; 33(31):7915-24. PubMed ID: 22841920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cells.
    McCarron PA; Marouf WM; Quinn DJ; Fay F; Burden RE; Olwill SA; Scott CJ
    Bioconjug Chem; 2008 Aug; 19(8):1561-9. PubMed ID: 18627195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway.
    Martins S; Costa-Lima S; Carneiro T; Cordeiro-da-Silva A; Souto EB; Ferreira DC
    Int J Pharm; 2012 Jul; 430(1-2):216-27. PubMed ID: 22465548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
    Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
    Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth.
    Figueiró F; Bernardi A; Frozza RL; Terroso T; Zanotto-Filho A; Jandrey EH; Moreira JC; Salbego CG; Edelweiss MI; Pohlmann AR; Guterres SS; Battastini AM
    J Biomed Nanotechnol; 2013 Mar; 9(3):516-26. PubMed ID: 23621009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
    Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
    Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro.
    Lanzilli G; Fuggetta MP; Tricarico M; Cottarelli A; Serafino A; Falchetti R; Ravagnan G; Turriziani M; Adamo R; Franzese O; Bonmassar E
    Int J Oncol; 2006 Mar; 28(3):641-8. PubMed ID: 16465368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nanocarriers for topical administration of resveratrol: a comparative study.
    Scognamiglio I; De Stefano D; Campani V; Mayol L; Carnuccio R; Fabbrocini G; Ayala F; La Rotonda MI; De Rosa G
    Int J Pharm; 2013 Jan; 440(2):179-87. PubMed ID: 22909994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.